文献速递咽喉与嗓音

侧方经颈入路门诊肉毒毒素注射治疗逆行性环咽功能障碍

Lateral Transcervical In-office Botulinum Toxin Injection for Retrograde Cricopharyngeal Dysfunction.
PubMed 文献 · Laryngoscope · 2023-07-08

本研究回顾性分析78次环咽肌注射肉毒毒素治疗逆行性环咽功能障碍,其中门诊侧方经颈入路37次、手术室41次。术后1个月门诊注射成功率64.9%,显著低于手术室的90.2%(p=0.022),副作用率无显著差异,早期与后期门诊注射的成功率和副作用率相似(p>0.05)。

要点

  • 门诊侧方经颈入路注射肉毒毒素治疗逆行性环咽功能障碍是安全方法,无需全身或局部麻醉。
  • 术后1个月门诊注射成功率64.9%,显著低于手术室注射的90.2%(p=0.022)。
  • 门诊与手术室注射的副作用率无显著差异;早期与后期门诊注射的成功率和副作用率相似(p>0.05)。

核心结论

  • 门诊侧方经颈入路肉毒毒素注射治疗逆行性环咽功能障碍是安全方法,无需全身或局部麻醉。
  • 虽然副作用相似且门诊注射有许多优势,但门诊注射成功率低于手术室注射。

研究设计与样本

  • 回顾性病历审查,纳入接受手术室或门诊肉毒毒素注射治疗逆行性环咽功能障碍的患者,共78次注射(门诊37次,手术室41次),由资深作者完成。
  • 术后成功定义为患者报告症状完全或接近完全缓解,比较各组副作用和并发症发生率。
  • 为确定门诊注射的学习曲线,比较早期和后期6个月注射的成功率。
  • 使用卡方检验确定统计学显著性。

主要发现

  • 术后1个月随访,手术室注射成功率90.2%,显著高于门诊注射成功率64.9%(p=0.022)。
  • 门诊注射与手术室注射的副作用率无显著差异。
  • 早期与后期门诊注射的成功率和副作用率相似(p>0.05)。

临床怎么用

  • 原文结论指出门诊侧方经颈入路肉毒毒素注射治疗逆行性环咽功能障碍是安全方法,无需全身或局部麻醉。
  • 原文结论指出虽然副作用相似且门诊注射有许多优势,但门诊注射成功率低于手术室注射。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Operating room (OR) injection of botulinum toxin (BTX) injection is effective in the management of retrograde cricopharyngeal dysfunction (RCPD). This study aims to analyze the efficacy and safety of in-office (IO) 30 Unit BTX injection into the cricopharyngeus via lateral transcervical approach. METHODS: A retrospective chart review of patients who underwent BTX injection either in the OR or IO for RCPD was performed. Postoperative success, defined by patient-reported complete or near complete resolution of symptoms, side effects, and complication rates of each group was determined and compared. To determine the learning curve of IO injections, success rates of the injections performed in the early and late 6 months were compared. Chi-square test was used for determining the statistical significance. RESULTS: Overall, 78 injections (37 IO and 41 OR) for RCPD were performed by the senior author. The success rate of OR injections (90.2%) is significantly higher than IO injections (64.9%) at the first-month follow-up (p = 0.022). No significant difference was found in the side effect rates. Success and side effect rates were also similar in early and late injections (p > 0.05). CONCLUSIONS: IO lateral transcervical BTX injection for RCPD is a safe method that does not require general or topical anesthesia. While the side effects are similar and IO injections have many advantages, the success rates are lower than OR injections. LEVEL OF EVIDENCE: 3 Laryngoscope, 134:283-286, 2024.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Doruk C, Pitman MJ. Lateral Transcervical In-office Botulinum Toxin Injection for Retrograde Cricopharyngeal Dysfunction. Laryngoscope. 2023. PMID: 37421251. doi:10.1002/lary.30871

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。